Overall rank by patents
#20,944
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,).
The verdict
According to USPTO PatentsView, Collectivehealth ranks #20,944 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R20944 · US Corporation #20,944 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Cleland Sales Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Collectivehealth · this assignee
41 score
3D Lighting Innovati… · lowest
7 score
What this shows Collectivehealth's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Collectivehealth, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2019. By volume, Collectivehealth sits between Cleland Sales Corporation and Compass Electro Optical Systems Ltd..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cleland Sales Corporation
13 patents
Cleveland Reclaim Industries
13 patents
Cogito Corporation
13 patents
CollPlant Ltd.
13 patents
Collegium Pharmaceutical, Inc.
13 patents
Colossio, Inc.
13 patents
Compart Systems Pte. Ltd.
13 patents
Compass Electro Optical Systems Ltd.
13 patents
CollectiveHealth, Inc.
13 patents
What this shows Collectivehealth holds 13 patents at rank #20,958, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,958 in granted patent volume.
Other assignees with the most granted patents in Collectivehealth's primary technology class.
Collectivehealth's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 33% higher than 67% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 7.7% |
| 2020 | 3 | 23.1% |
| 2022 | 4 | 30.8% |
| 2024 | 4 | 30.8% |
| 2025partial year | 1 | 7.7% |
Top 4 of 4 technology areas
Overall rank by patents
#20,944
of 50,000 tracked assignees
41.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.